MedTech Investing Conference Register Now! IBF Conferences – International Business Forum LifeScience Alley™ Home


2009 Speakers


End of Speakers List

Michael Berman
Michael Berman
Medical Device Venture Catalyst
Berman Medical
Michael Berman is a Medical Device Entrepreneur and Investor working with a select group of high potential early stage companies. From 1995-2000 Mr. Berman was President of Boston Scientific/Scimed. From 1997 to 2000 he was a member of Boston Scientific’s Executive Committee. Mr. Berman is currently on the board of the following companies: Aetherworks I and II since 2003 (Co-Founder), Apnex, since 2005 (Co-Founder), Benechill, since 2004 (Co-Founder), BridgePoint Medical, since 2005 (Co-Founder), CoAxia, since 2000, Conceptx, since 2007 (Co-Founder), Lutonix, since 2007, PharmaCentra, since 2005, Sage Medical, since 2004 (Co-Founder), Transoma Medical, since 2001, and UltraShape, since 2005. In addition in 2000 Mr. Berman co-founded Velocimed, and served as a board member until the company was sold to St. Jude Medical in April 2005. 2009 Speakers List

 
Richard Bowman
Richard Bowman
President
Debt Advisors Group
Rich Bowman has over 30 years of experience in asset management, commercial lending and equipment leasing, most notably in the high technology and life science industries.  As President of Debt Advisors Group, Rich oversees the rigorous process of analyzing and selecting various debt products, agreeing on terms and developing debt solutions that meet clients’ objectives.  Prior to founding Debt Advisors Group, Rich was a Vice President at General Electric – Life Sciences and Technology Finance, where he oversaw the sourcing, negotiation, closing and documentation of debt transactions for Biotech companies in northern New England.  He has also held senior positions at Comdisco, Inc. and Equitable Life Leasing Corporation. Rich holds his FINRA Series 65 license. 2009 Speakers List

 
Elizabeth Brown, MD
Elizabeth Brown, MD
Board Certified Pathologist
Elizabeth Brown, MD is a board certified pathologist who has spent the last 20 years in the field of technology assessment and coverage policy development.  She was the Director of Technology Assessment at the American Medical Association, then Medical Director for medical policy at Aetna and held a similar position at the Blue Cross Blue Shield Association for 10 years.  She has also worked in the medical policy department at Anthem.  Over the course of her career, she has written literally hundreds of medical policies and technologies addressing diagnostic devices, drugs and procedures, and participated in the evolution of the payor coverage policy process and the changing landscape of evidence-based coverage policies. 2009 Speakers List

 
Chad Cornell
Chad Cornell
Vice President, Corporate Development
Medtronic, Inc.
Chad Cornell is Vice President, Corporate Development for Medtronic, Inc.   Chad has responsibility for supporting Medtronic’s CardioVascular business unit (vascular therapies and cardiac surgery therapies), as well as other strategic initiatives within Medtronic.  Chad works in partnership with executive and business unit management in evaluating and executing mergers and acquisitions, strategic alliances, joint ventures, minority investments, technology licenses, divestitures and other strategic transactions.  Chad also assists in Medtronic’s strategic planning process.

Prior to joining Corporate Development, Chad was Legal Counsel – M&A, responsible for advising Corporate Development on strategic transactions across Medtronic.  Chad began his career with Medtronic in 2003.  Prior to joining Medtronic, Chad spent approximately five years as an associate attorney at Sidley & Austin in Chicago, Illinois working on mergers and acquisitions and securities offerings.

Chad received his undergraduate degree in Accounting from Marquette University and a Juris Doctorate from the University of Pennsylvania.  Chad has also successfully completed Certified Public Accountant and Chartered Financial Analyst examinations. 2009 Speakers List

 
Mark E. DuVal
Mark E. DuVal
President
DuVal & Associates, P.A.
Mark E. DuVal, JD is President of DuVal & Associates, where he counsels both mature and venture-backed pharmaceutical, medical device, and biotech companies in the United States and Europe in addition to working extensively with combination products.  DuVal regularly advises clients in all areas of FDA law and regulation, from product development, clinical trials, inspections and recalls to reimbursement and compliance issues and post-marketing responsibilities.  He specializes in counseling medical device and pharmaceutical companies in the development and implementation of strategic and tactical sales and marketing plans that are appropriately aggressive, yet compliant. 2009 Speakers List

 
Kevin Davies
Kevin Davies
Managing Director & Co-Head of U.S. Healthcare Investment Banking
RBC Capital Markets
Kevin Davies is a Managing Director and Co-Head of U.S. Healthcare Investment Banking at RBC Capital Markets.  Mr. Davies has served healthcare clients exclusively since 1995, and has completed over 80 corporate finance and merger and acquisition transactions totaling over $40 billion across a broad spectrum of healthcare sectors, including medical technology, biotechnology, specialty pharmaceuticals and healthcare services.  Prior to joining RBC, Mr. Davies spent over five years at Lehman Brothers and Morgan Stanley and was Head of Medical Technology Investment Banking at Wells Fargo Securities and at Robertson Stephens.  Mr. Davies received a Bachelor of Commerce degree from the University of Toronto, a Masters of Business Administration from the J.L. Kellogg Graduate School of Management at Northwestern University and is a Chartered Financial Analyst (CFA). 2009 Speakers List

 
Robert A. DeSutter
Robert A. DeSutter
Managing Director & Co-Head of Health Care
Piper Jaffray
Bob DeSutter is a managing director and co-head of the Health Care Team and has 16 years of investment banking experience.  DeSutter started the health care advisory practice in 1996 and has transaction experience on numerous buy-side/sell-side, friendly/hostile, strategic/financial buyer and public/private deals.  Since 1998, he has advised life sciences clients on sale transactions to Abbott Labs, Astra, Biomet, Boston Scientific, Cardinal Health, Thermo Fisher, Medtronic, Johnson & Johnson, Pfizer, St. Jude, Covidien, Smith & Nephew, GE Medical and Novartis, among others. DeSutter has completed financing transactions involving public and private equity, convertible debt, subordinated debt and senior secured debt.

DeSutter is a graduate of the University of Minnesota and the University of Virginia's Darden Graduate School of Business. 2009 Speakers List

 
Todd Evans
Todd Evans
Director, Pharmaceuticals and Life Sciences
PricewaterhouseCoopers
Todd Evans is a director in PricewaterhouseCoopers Pharmaceutical and Life Sciences Advisory Services Group.  He has spent over 25 years as an international trade executive and industry strategy consultant with broad-based experience in industry management and professional services.  His business background includes 12 years of P&L ownership, with eight spent as an expatriate in Europe responsible for EMEA.  He has extensive pharmaceutical / life sciences, high technology, aerospace and automotive industry experience in corporate restructuring, product channel strategy, go to market strategy, supply chain strategy, pricing strategy and international trade strategy.  His background includes success in entrepreneurial business innovation and management.  He has led many corporate strategy projects and large scale, transformational, strategic consulting programs.  He is a PricewaterhouseCoopers thought leader and presently leads the firm's Pharmaceutical and Life Science Sales and Marketing Strategy team. 2009 Speakers List

 
Nathan Every, MD, MPH
Nathan Every, MD, MPH
General Partner
Frazier Healthcare Ventures
Dr. Every is responsible for evaluating opportunities in the medical device and biotech sectors.  He joined Frazier Healthcare 1999, became Partner in 2001 and General Partner in 2005.  He was integral to the formation of Synecor, a first-of-its-kind accelerator company backed by researchers, corporations, clinicians and a leading investment bank.  He founded and was start-up CEO for MacuSight, an ocular disease therapy company that was incubated at Frazier Healthcare.  He currently serves on the boards of directors at BARRX, Calibra Medical, FlowCardia, InnerPulse, MacuSight, PowerVision, Xoft, and Zeltiq Aesthetics.  Before joining Frazier Healthcare, Dr. Every was an associate professor of medicine and director of the Cardiovascular Outcomes Research Center at the University of Washington, where he performed multiple studies evaluating the costs and outcomes of new procedures and pharmaceutical agents.  His findings have been published in more than 75 scientific articles, including The New England Journal of Medicine, JAMA and The Lancet.  Dr. Every earned an M.D. from Emory University School of Medicine and a master of public health (M.P.H.) degree from the University of Washington School of Public Health. 2009 Speakers List

 
Richard Ferrari
Richard Ferrari
Managing Director
De Novo
Mr. Ferrari is a Co-Founder of De Novo Ventures which has $650 million under management which is dedicated to Medical Devices and Bio-Technology. Rich has been a successful CEO of two publicly traded medical technology companies. Cardiovascular Imaging Systems, the first and leading developer of ultrasound imaging catheters and CardioThoracic Systems (CTS), the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery. Rich was a co-founder of CTS and the force that led the company to an initial public offering in only 7 months, the fastest of any medical technology company in history. Mr. Ferrari is the recipient of the Mallinckrodt Award for Excellence in Medicine and has been a finalist for the Entrepreneur of the Year Award. Rich holds a BS degree from Ashland University and an MBA from the University of South Florida. 2009 Speakers List

 
Don Gerhardt
Don Gerhardt
President & CEO
LifeScience AlleyTM
Prior to joining LifeScience Alley, Don was involved in the health care industry serving in top-level positions including: CEO of MedCenters Health Plan, administrator of Michigan State University medical facilities, Kaiser Permanente, a consultant for health care start-up companies and business coalitions, an officer for a high tech health care data company, and with several international health care businesses.  He currently sits on the board for two medical technology companies.  He is a frequent speaker and contributing writer to health care related articles and books.  His education includes Concordia College in Moorhead, Minnesota, a Masters degree in Health Administration from the University of Colorado, and postgraduate study in finance and statistics from Ohio State University.  He is a faculty member at the University of St. Thomas, and sits on the Advisory Boards of the University of Minnesota's Biomedical Engineering Institute, the College of Pharmacy, the Institute of Technology, and the School of Nursing.  Don also serves on the board of directors of Biomedical Commercialization Canada, Inc., the Bakken Museum, and the Greater Minneapolis Convention and Visitors Association. 2009 Speakers List

 
Sami Hamadé
Sami Hamadé
Partner
Aberdare Ventures
Sami Hamadé joined Aberdare as a Partner in 2006.  Prior to Aberdare, Sami was Vice President at the Guidant Corporation and head of the Compass Group, where he was responsible for Guidant's venture capital and M&A activities.  Additionally, Sami led the West Coast Business Development unit which was composed of business development groups from Vascular Intervention, Cardiac Surgery and Endovascular Solutions divisions.  Previous to this, Sami played founding roles in the launch and development of significant businesses for Guidant including coronary stents, carotid and peripheral systems.  Sami began his career in medical devices at Advanced Cardiovascular Systems.  Sami holds a Bachelors degree in Engineering from the American University of Beirut, a Masters Degree in Engineering from the University of Michigan, Ann Arbor and an MBA from the Stanford Graduate School of Business. 2009 Speakers List

 
Jay Hare
Jay Hare
Partner
PricewaterhouseCoopers
Jay Hare is one of ten partners in PricewaterhouseCoopers’ Twin Cities practice serving the technology industry.  This market leading practice includes technology companies ranging from venture backed to the Fortune 500.  Jay’s focus is technology businesses primarily in the sectors of software and life sciences.  Jay has been involved in PwC's MoneyTree Venture Capital Survey for the last eleven years tracking quarterly trends and commenting on these trends to the Minneapolis/St Paul Star Tribune.2009 Speakers List

 
William (Bill) Harrington
William (Bill) Harrington
Partner
Three Arch Partners
Bill has been with Three Arch Partners since 1999 and has been active in medical device health care service and biotechnology investing.  He currently sit on the boards of Cameron Health, NeuroVista, Satiety, Baxano, Benvenue, Centerre, APT Pharmaceuticals, and others.  Following medical school, Bill did his postgraduate training in internal medicine and diagnostic and interventional radiology at University of California, San Francisco.  Before joining Three Arch, he practiced as an interventional radiologist for nine years, and maintained a clinical faculty appointment at University of California, San Francisco.

He has broad experience with a wide variety of medical devices, minimally invasive surgical procedures, and related clinical trials.  He was a founder of Bay Medical Management.  Bill received his BS in Biology and Chemistry from Tufts University where he graduated summa cum laude.  He obtained his MD from Harvard Medical School.  He completed his MBA at the Haas School of Business at the University of California, Berkeley.  Bill is a CFA charter holder. 2009 Speakers List

 
Ann Hickey, MD
Ann Hickey, MD
Vice President, New Business Development
ev3, Inc.
Ann is Vice President of New Business Development for ev3, Inc.  Ann leads business development efforts and supports the strategic planning process for ev3’s Peripheral Vascular Division.  Prior to joining ev3 in 2003, Ann served in marketing at Medtronic’s Neurological Division.  She earned a Bachelors of Science from the University of Notre Dame, a Doctorate of Medicine from Ohio State University, and a Master of Business Administration from the University of Michigan. 2009 Speakers List

 
Jeff Hoffman
Jeff Hoffman
Managing Director
Head of West Coast Healthcare Investment Banking
JP Morgan Securities Inc.
He has more than 18 years experience in the full range of investment banking activities including financial advisory services, mergers and acquisitions, equity and debt financings, and venture capital investments.  At J.P. Morgan, Mr. Hoffman serves as the lead Client Executive for clients such as Abbott, Allergan, Bausch & Lomb, Biomet, Medtronic and Zimmer, among others.  Mr. Hoffman earned his BA and MBA at the University of North Carolina at Chapel Hill in 1989 and 1993, respectively. 2009 Speakers List

 
Marie Guion Johnson, PhD
Marie Guion Johnson, PhD
Director
Medical Devices Center Innovation Fellows Program University of Minnesota
Marie Guion Johnson, Ph.D. is the newly appointed director of the Medical Devices Center Innovation Fellows Program.  The Fellows program is a full immersion education and product development program, which brings together a four person team of post doctoral engineers and medical doctors to develop medical devices.  The team collaborates for one year to identify and solve unmet clinical needs through a disciplined decision making technique which includes consideration of clinical literature, FDA regulatory pathway, insurance reimbursement, intellectual property and business strategies.  This experience also includes prototyping and testing of medical devices at the new Medical Devices Center on the University of Minnesota Campus.  The team goal is to save lives, improve health care and create jobs through the development of commercially viable medical products.

Dr. Johnson is a graduate in Mechanical Engineering from Kettering University and received her M.S. and Ph.D. degrees in Biomedical Engineering from the University of Minnesota.  She spent over a decade in a variety of manufacturing and R&D positions at General Motors Corporation and most recently was the 2007 Simon Stertzer Fellow in the Stanford Biodesign Program.  She is above all else an innovator, and holds multiple patents on orthopedic, cardiovascular and obstetrics medical devices. 2009 Speakers List

 
V. Kadir Kadhiresan, PhD
V. Kadir Kadhiresan, PhD
Principal
Johnson & Johnson Development Corporation
Kadir joined Johnson & Johnson Development Corporation’s Medical Device Investment Team in 2007 and focuses on opportunities throughout the United States.  Kadir has more than a decade of operational experience in various functional roles including research, product development and business development.  Most recently as Director of Business Development at Guidant Corporation/BSX, Kadir led transactions in several novel medical device technologies for joint development, M&A and licensing and monetizing non-strategic assets.  Prior to business development, in R&D, Kadir led the development of several early stage technologies by managing more than 60 people and ~$12 MM annual budget.  Kadir was also instrumental in the development of the cardiac resynchronization therapy for heart failure, now > $2B market worldwide.  At Heart Rhythm Technologies (a subsidiary of Guidant), Kadir led the development of an ablation technology for treatment of atrial fibrillation and raised venture finance for the project.  Kadir is an inventor on more than 25 patents and has published several articles in peer-reviewed journals.  Kadir holds a MBA from the Kellogg School of Management at Northwestern University, Evanston, IL.  He also graduated with a BS in Electrical Engineering from REC, Trichy, India and MS and PhD in Biomedical Engineering from University of Michigan, Ann Arbor, MI.  Kadir serves on the board of JJDC portfolio companies. 2009 Speakers List

 
William Kaufman
William Kaufman
Partner, Corporate Finance and Transactions Group
Oppenheimer Wolff & Donnelly LLP
Focusing his practice in the areas of corporate securities, corporate finance and venture capital transactions, Mr. Kaufman he has been involved with numerous private placements, joint ventures, structured financing transactions, and mergers and acquisitions.  He has acted as company counsel or investor’s counsel in more than 230 venture capital investment transactions and has served as company counsel for numerous emerging high-tech businesses, particularly in the medical device and software industries; has managed hostile takeover matters; and has represented regulated companies in acquisitions, structured financings and asset dispositions.  Mr. Kaufman has served as issuer’s counsel and underwriter’s counsel for public offerings and has acted as special counsel to institutional selling shareholders in numerous public offerings.  He has been involved with a number of private placements, including high-tech and medical devices start-up financings.  His corporate work has involved employment agreements, clinical trial agreements, numerous technology licenses, domestic and international distribution agreements and strategic investments for his clients.  He also structured and formed venture capital funds, and worked on SEC informal investigations.  He received his Bachelors in Finance and Economics from the University of Notre Dame, 1973, magna cum laude, and his J.D. degree from the University of Minnesota Law School, 1976, cum laude.  Minnesota Law & Politics has named Mr. Kaufman a “Super Lawyer” in its Securities and Venture Finance category every year since 2003. 2009 Speakers List

 
Douglas W. Kohrs
Douglas W. Kohrs
President and CEO
Tornier, Inc.
Douglas W. Kohrs was appointed as the President and CEO of Tornier, Inc on July 18, 2006.  He has a 27 year record of success and accomplishment in the medical device industry.  He served as President and CEO of American Medical Systems (“AMS”) from 1999 until February, 2005, and served as Chairman of the AMS Board until May 2006.  Over the past 10 years, Mr. Kohrs has also served on the board of directors of nine different medical device companies.  Prior to joining AMS, Mr. Kohrs was General Manager of Sulzer Spine-Tech, a company that he was a founding member of beginning in August, 1991.  Mr. Kohrs has also held leadership positions in the orthopedic industry with Johnson and Johnson Orthopaedics and Zimmer.  Mr. Kohrs received a B.A. in Engineering Sciences from Austin College, a B.S. in Bio-Engineering from Texas A & M University, and an MBA from Northeastern University.2009 Speakers List

 
Carter McNabb
Carter McNabb
Managing Director
River Cities Capital Funds
Carter McNabb joined River Cities Capital Funds in 1999 and leads the firm’s healthcare investing practice with concentration on medical device and technology-enabled healthcare service companies.  While at River Cities, Carter has led and participated in 14 healthcare investments for River Cities, including successful exits with Suros Surgical Systems, National Medical Solutions, CMHC Systems and Foresight Corp.  He currently serves as Director on the boards of OrthoHelix Surgical Designs, OrthoScan, Health Integrated, AcceleCare Wound Centers, and PerfectServe.  Prior to joining River Cities, Carter worked in equity research at J.C. Bradford & Co., a leading regional investment bank now part of UBS.  He began his career in marketing and business development for Home Technology Healthcare, a comprehensive home healthcare company offering nursing, DME, infusion therapy and hospice across the southeast.  Home Technology Healthcare was private equity financed by the Bank Fund and acquired by Integrated Health Services in 1997.  Carter received his MBA from Vanderbilt University where he was recipient of the Bradford Fellowship for achievements in corporate finance.  He completed his undergraduate studies at Trinity College in Hartford, CT. 2009 Speakers List

 
Peter McNerney
Peter McNerney
Partner
Thomas McNerney Partners
Pete has over 30 years of health care operating and venture capital experience.  In addition to co-founding Thomas, McNerney & Partners, Pete co-founded Coral Ventures in 1992 where he was responsible for health care investing.  Pete is currently a board member of a number of companies.  Prior to joining Coral in 1992, Pete was a co-founder and Managing Partner of The Kensington Group, a firm specializing in providing management services to early stage companies in the health care field.  In 1986, he founded and was Chief Executive Officer of Memtec North America.  Previously, Pete spent 11 years with Baxter Healthcare Corporation, where he held various general management positions in the U.S., Europe, the Middle East and Southeast Asia.  He currently serves on the Board of Trustees of Blue Cross and Blue Shield of Minnesota.  A Certified Public Accountant, Pete received a B.A. from Yale and an M.B.A. from Stanford University. 2009 Speakers List

 
Scott Miller
Scott Miller
Vice President, Corporate Development & Licensing
Covidien, Ltd.
Scott Miller is Vice President, Corporate Development & Licensing for Covidien, Ltd., a leading global healthcare products company providing innovative medical devices, medical supplies and pharmaceutical solutions for better patient outcomes.  Scott partners with the leadership of a number of Covidien’s global businesses to execute mergers and acquisitions, technology licenses, alliances, joint ventures and other transactions in support of key strategic objectives.  Before joining Covidien, Scott served as Senior Director of Business Development for Edwards Lifesciences, Inc. Prior to joining Edwards Lifesciences, Scott practiced law at Paul, Hastings, Janofsky & Walker LLP, where he specialized in corporate finance and mergers and acquisitions law.  Prior to practicing law, Scott worked as the CFO for a high-tech start-up and as a financial analyst in Weyerhaeuser Company’s corporate venture capital business.  Scott received his Master of Business Administration from the UCLA Anderson School of Management, his Juris Doctorate from Loyola Law School and his Bachelor of Arts in Economics from the University of California at Irvine. 2009 Speakers List

 
Randall Nelson
Randall Nelson
President
Evergreen Medical Technologies, LLC.
Randall Nelson is President of Evergreen Medical Technologies, LLC.  Evergreen develops medical devices for inventors and early stage medical device companies from the concept stage through product development with cleanroom assembly and packaging capabilities as well.  For some emerging companies, Evergreen has become their product development department.  Previously, Mr. Nelson has been responsible for the development of Class II and Class III medical devices for over 25 years at both emerging and larger companies.  He has a Mechanical Engineering degree from the University of Minnesota, an Economics degree from Willamette University in Salem, Oregon and is an Adjunct Faculty member of the Carlson School of Management, University of Minnesota. 2009 Speakers List

 
Evan Ng
Evan Ng
Partner
Dorsey & Whitney
Evan Ng is a partner with Dorsey & Whitney and he is co-chair of the firm’s Life Sciences and Health Care Group.  He has substantial experience representing public and private life science companies across a broad range of matters that include venture capital and private equity financings, initial public offerings, mergers and acquisitions and strategic technology transactions.

In addition to maintaining an active specialty practice focused on the life science industry, Evan frequently advises underwriters on public offerings and private equity sponsors in the negotiation and execution of buyout transactions. Evan also advises U.S. companies and investors with respect to operations and investments in China, and is fluent in Cantonese and Mandarin. 2009 Speakers List

 
Jonathan Norris
Jonathan Norris
Managing Director, Private Equity Group
Silicon Valley Bank
Jon Norris is a managing director with SVB Capital’s Private Equity Group, specializing in life sciences.  Norris has more than seven years of banking experience focused on working with life science companies and venture capital firms.  In his current role, Norris is responsible for strengthening relationships with select venture capital firms by leveraging SVB’s platform of strategic business units, including investment and commercial banking, as well as global and analytical services.  Prior to joining SVB Capital, Norris was a founding member and senior vice president of Square 1 Bank, an early stage technology bank.  Norris also served more than six years at Imperial Bank (subsequently acquired by Comerica Bank), most recently as senior vice president and group manager of the Northern California Life Science Practice.  Norris earned a bachelor’s degree in business administration from the University of California, Riverside and a juris doctorate from Santa Clara University. 2009 Speakers List

 
Brent J. O’Connell, M.D., M.H.S.A.
Brent O’Connell, MD
Chief Medical Officer
Argenta TEC Advisors
Dr. O’Connell has been employed by Highmark, one of the nation’s largest insurers for fifteen years.  During that time, he held various positions including Medical Director, Vice President & Medical Director, and Vice President and Senior Medical Director.  He has extensive experience with all plan operations and medical and payment policy.  He was responsible for all medical policy for the company during his time of employment.  He was active nationally and served as the Chairman of the Blue Cross Blue Shield Association’s (BCBSA) Medical Policy Panel for six years and a member of the BCBSA Technology Evaluation Center’s Medical Advisory Panel for four years.  He was appointed as a member of the Medicare Coverage Advisory Committee (MCAC) in 2006.  A native of Northeastern Pennsylvania, Dr. O’Connell earned his medical degree from Jefferson Medical College in Philadelphia.  He completed his pediatric residency program at Polyclinic Medical Center in Harrisburg and was board certified in pediatrics in 1975.  Dr. O’Connell received his master’s degree in Health Service Administration in 1998.  He completed his undergraduate work at Wilkes University, where he was named “Outstanding Graduate of the Year” upon receiving his diploma. 2009 Speakers List

 
Stephen N. Oesterle, MD
Stephen N. Oesterle, MD
Senior Vice President for Medicine and Technology
Medtronic
Stephen N. Oesterle, M.D., joined the company in 2002 as Senior Vice President for Medicine and Technology.  In this role, Steve provides executive leadership for Medtronic scientific research, formation of technological strategies and continued development of strong cooperative relationships with the world's medical communities, technical universities, financial institutions and emerging medical device companies.  Previously, Steve served as Associate Professor of Medicine at the Harvard University Medical School and as Director of Invasive Cardiology Services at Massachusetts General Hospital, Boston.  A teacher and innovator in the field of cardiac catheterization, he has also developed and directed interventional cardiology programs at Good Samaritan Hospital, Los Angeles; at Georgetown University; and at Stanford University.  Steve is a 1973 summa cum laude graduate of Harvard College and received his medical doctorate from Yale University in 1977.  He completed his internship and residency at Massachusetts General Hospital and also served a fellowship in interventional cardiology at Stanford. 2009 Speakers List

 
Mike Partsch
Mike Partsch
Founder & CEO
AcceleMed Management, Inc.
Mike Partsch has 20 years of experience in venture investing and start-up company development, and has concentrated on the life sciences industry since 1989 when he was a founding member of a biotechnology company called Neose Technologies.  During his career he has honed his skills for interacting with entrepreneurial management teams.  Most recently, Mike founded AcceleMed Management, which sources, founds and manages innovative medical device companies.  Through AcceleMed, Mike serves as management for a portfolio of medical device start-ups.  Additionally, Mike currently serves as a board member for MyoScience (Menlo Park).  Before founding AcceleMed, Mike was one of the founders of Accuitive Medical Ventures (AMV), a venture capital firm focused on investing in early stage medical device technologies.  Prior to helping form AMV, Mike worked for three years with Versant Ventures, and during his fellowship worked for EDF Ventures in Ann Arbor, MI, where he served as interim CFO of IntraLase, Corp. and founded HandyLab Inc.  He previously worked at the CEO Venture Fund where he was responsible for reviewing much of the life science deal flow for the firm while attending business school.  Mike received a dual major Bachelor's degree in Biology and Philosophy of Science with a minor in Chemistry from the University of Pennsylvania, and holds an MBA from Carnegie Mellon University with dual concentrations in Finance and Entrepreneurship. 2009 Speakers List

 
J. Robert Paulson
J. Robert Paulson
President & CEO
NxtThera, Inc.
Bob Paulson is President, CEO and a Director of NxThera, Inc., a venture-backed, early-stage medical device company developing novel thermal therapy devices to treat men’s health issues.  Prior to joining NxThera in early 2009, Bob was President, CEO and a Director of Restore Medical from 2005 until the company’s acquisition by Medtronic in July of 2008.  From 2002 - 2005, Bob was CFO and VP of Global Marketing for Endocardial Solutions, which was acquired by St. Jude Medical in January of 2005.  Previously, Bob was Sr. VP/General Manager of Advanced Bionics, and held several executive positions with Medtronic, including VP/General Manager of the Surgical Navigation Technologies business, VP Corporate Strategy, and Director of Corporate Development.  Bob held a variety of marketing, corporate development, legal and financial positions at General Mills, and practiced corporate, M&A and securities law with the Minneapolis law firm of Lindquist & Vennum.  Bob has served on the Board of Directors of several private, venture-backed and publicly-traded medical device companies. 2009 Speakers List

 
Don St. Pierre
Don St. Pierre
Associate Director for Policy and Operations
Office of In Vitro Diagnostic Device Evaluation and Safety
Don St.Pierre graduated with honors in 1985 with a Bachelor’s Degree in Engineering Science and Mechanics from Penn State University.  He spent 3 years testing medical devices in FDA’s field engineering laboratory before coming to the Center for Devices and Radiological Health’s (CDRH’s) Office of Device Evaluation (ODE) in January 1990.  At ODE, he worked in various divisions – starting as a reviewer in the Division of Cardiovascular Devices, then moving on to the Division of Reproductive, Abdominal, Ear, Nose and Throat and Radiological Devices as a reviewer in the Urology and Lithotripsy Devices Branch.  In November 1995, he became the Branch Chief of the Urology Branch; in April 2000, he became the Deputy Director of the Division of Clinical Laboratory Devices; and in November 2002, he became the Deputy Director for New Device Evaluation in the Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD) and currently serves as the Associate Director for Policy and Operations in OIVD. 2009 Speakers List

 
Howard Root
Howard Root
CEO and Co-Founder
Vascular Solutions
Howard Root has served as Chief Executive Officer since he co-founded Vascular Solutions, an interventional medical device company, in February 1997.  From 1990 to 1995, Mr. Root was employed by ATS Medical, Inc., a mechanical heart valve company, most recently as Vice President and General Counsel.  Prior to joining ATS Medical, Mr. Root practiced corporate law, specializing in representing emerging growth companies, at the law firm of Dorsey & Whitney LLP for over five years. 2009 Speakers List

 
Luke Sarsfield
Luke Sarsfield
Managing Director
Goldman, Sachs & Co.
Luke is global head of the medical device investment banking practice.  He joined the firm’s Healthcare Group in 1999 and served as the group’s business unit manager in 2002.  He was named managing director in 2007.  Prior to joining Goldman Sachs, Luke was a consultant for McKinsey & Co. and a healthcare investment banker at Credit Suisse First Boston.  Luke is vice chair of the Board of Directors of Literacy, Inc., a New York City-based nonprofit focused on promoting early childhood literacy.  Luke received his MBA from Harvard Business School and his BA in Anthropology, magna cum laude, from Harvard College. 2009 Speakers List

 
Jonathan Silverstein
Jonathan Silverstein
General Partner
OrbiMed Advisors LLC
Mr. Silverstein is a General Partner of OrbiMed, as asset management firm solely focused in healthcare with more than $6 billion in assets under management.  Mr. Silverstein joined OrbiMed in 1998 to focus on private equity and structured transactions in small capitalization public biotechnology and medical device companies.  Mr. Silverstein was previously a Director of Life Sciences in the Investment Banking Department at Sumitomo Bank.  Mr. Silverstein has a J.D. and an M.B.A. from the University of San Diego, and a B.A. in Economics from Denison University.  Currently, Mr. Silverstein is a Director of Cerapedics, SuperDimension, Enobia, Gelesis and Insulet Corporation (PODD).  He has been a former director or observer in more than a dozen other companies including: LifeCell (LIFC), Given Imaging (GIVN), Cerexa (sold to Forest Labs), Peninsula Pharmaceuticals (sold to JNJ), Predix (sold to EPIX), Avanir (AVNR), Orthovita (VITA), Auxillium (AUXL), Bioenvision (sold to Genzyme), Adiana (sold to Cytyc), Adolor (ADLR) and Emphasys Medical. 2009 Speakers List

 
Paula R. Skjefte
Paula R. Skjefte
President & Chief Executive Officer
Waterford Consulting
Paula R. Skjefte is the President and Chief Executive Officer of Waterford Consulting.  Her company’s focus is driving strategic growth through new product innovation, disruptive approaches to the market, and creative commercialization roadmaps in the medical device marketplace.  Paula is an experienced medical device executive with over 25 years of medical/healthcare experience, including 16 years at Medtronic, Inc.  Paula serves on the board of Angeion Corporation (ANGN) and is the Chair of the Compensation Committee.  She is member of National Association of Corporate Directors, Women Corporate Directors, and Twin Cities Angels.  She earned a Masters in Business Administration from the University of Minnesota and a Bachelor of Science in Nursing from the University of Wisconsin. 2009 Speakers List

 
Daniel Sullivan
Daniel Sullivan
President & CEO
superDimension
Mr. Sullivan is the president and CEO of superDimension, Inc.  superDimension is commercializing a breakthrough technology that allows a catheter to be threaded through the mouth to the deep lungs, to facilitate the diagnosis and treatment of early stage lung cancer.  Lung cancer is the number one cancer killer and this technology represents a platform into a potential $7 billion market.  He began his career at American Hospital Supply in 1979 and is a veteran of 11 start up medical technology companies, 10 of which have been successful.  Most notably, he was one of the key executives who built SCIMED Life Systems, Inc. which is now a major part of Boston Scientific, Inc.  He has a business degree from Arizona State University and spends his spare time flying MIG fighter jets at airshows. 2009 Speakers List

 
Eric Tardif
Thomas D. Weldon
Senior Vice President, Corporate Strategy
Gen-Probe Incorporated
Mr. Tardif joined the Company as Senior Vice President, Corporate Strategy in 2009.  Prior to Gen-Probe, Mr. Tardif was a managing director in Morgan Stanley’s healthcare investment banking group, focused on providing strategic and financial advisory services to diagnostics, life sciences tools and medical technology companies.  Before joining Morgan Stanley in 2006, Mr. Tardif was an investment banker with Piper Jaffray from 2003 to 2006, and with Merrill Lynch from 1999 to 2003.  He received his BA from Bishop’s University in Québec, his MBA from the University of British Columbia, and his Master of Science in Finance from the Boston College Carroll Graduate School of Management.  Mr. Tardif holds a chartered financial analyst (CFA) designation. 2009 Speakers List

 
Fredrik P. Tolin, MD, MBA, FACS
Fredrik P. Tolin, MD, MBA, FACS
Medical Director
Chicago Commercial Market
Dr. Fredrik Tolin studied chemical engineering at the University of Kentucky, and completed his medical degree at the University Of Pittsburgh School Of Medicine.  He started his residency in surgery at Louisiana State University School of Medicine, finishing at the University of Chicago.
 
Dr Tolin was in private practice of surgery in the Chicago suburbs, where he concentrated on the management of breast cancer and advanced laparoscopic surgery, prior to a career change to administrative medicine.
 
Currently, Dr. Tolin is the Medical Director for Humana’s Chicago Commercial Market, and is also involved with policy development and implementation.  He has maintained his clinical appointment at the University of Illinois at Chicago in the Department of Surgery. 2009 Speakers List

 
Tom Waddell
Tom Waddell
Principal
Project Leadership Services
Tom Waddell is an expert in technical project management, small company executive management, product development and process reengineering.  In addition, he has proven expertise in project management, executive management, strategic and long-range planning, organizational development, product engineering, process design, and manufacturing engineering and management.  Drawing on over 20 years of hands-on experience, Tom has managed product development and engineering projects for organizations ranging from Fortune 500 companies to entrepreneurial startups.  His expertise also extends across industries, including medical products, semiconductors, manufacturing, finance and government.  An alumnus of the University of Wisconsin-Madison with a BS in Electrical Engineering, Tom has held positions including Project Manager, President & CEO, VP Operations and Product Engineer. 2009 Speakers List

 
Dennis W. Wahr, MD
Dennis W. Wahr, MD
President/CEO/Co-Founder
Lutonix
Dennis W. Wahr, MD co-founded Lutonix in April 2007 where he serves as President and CEO.  He has 25 years of experience in medical device company operations and in clinical practice as a board certified interventional cardiologist.  Lutonix represents Wahr’s second entrepreneurial effort having also been the co-founder, President, and CEO of Velocimed LLC.  At Velocimed Wahr led the invention, development, clinical evaluation, and commercialization of three innovative, minimally invasive cardiovascular and neurovascular devices.  He led Velocimed through four financing events and the M&A with St. Jude Medical in April 2005.  Following the sale of Velocimed, Wahr spent 2 years working with RiverVest Ventures as a Managing Director.  He led several investments on behalf of RiverVest and continues to serve on the board of Accumetrics.  Wahr trained in Cardiology at the University of California, San Francisco and practiced in Ann Arbor, MI. 2009 Speakers List

 
Kevin Wasserstein
Kevin Wasserstein
Managing Director
Versant Ventures
Kevin Wasserstein is a Managing Director at Versant Ventures, a leading healthcare-focused venture capital firm targeting early-stage investments across healthcare.  Kevin brings more than fifteen years of venture capital and operating experience in medical device and high technology companies, and specializes in investing and building medical device companies from their earliest seed or concept stages through their entire life cycle.  Prior to joining Versant in 2002, Kevin served in a variety of marketing and business development roles at Guidant Corporation, including acting as the Director of Marketing in Guidant's Cardiac Surgery Group, and serving in Guidant's Compass Business Development Group, where he was involved in acquisition, licensing and investment activities with both private and public medical device companies, and in formulating corporate strategies to develop innovative medical technologies.  Kevin currently serves, or has served, in a variety of board or advisory roles with companies which include: Acclarent, Cellutions, LipoSonix, NDO Surgical, NeoGuide Systems, Rox Medical, Second Sight Medical, St. Francis Medical (sold) and The Innovation Factory.

Kevin holds both Bachelor's and Master's degrees in Mechanical Engineering, as well as an MBA, all from Stanford University. 2009 Speakers List

 
Thomas D. Weldon
Thomas D. Weldon
Chairman, Managing Director
The Innovation Factory
As a co-founder and chairman of the medical device incubator The Innovation Factory (TIF), Tom brings over 25 years of operating experience, as well as critical fundraising skills in the medical device industry.  Tom also co-founded and serves as the chairman of Accuitive Medical Ventures, which currently has over $230MM under management. Previously he was a co-founder of Novoste Corporation, the intracoronary radiation therapy company where he served as chairman and CEO of Novoste from its inception in 1992, and led the company through its initial public offering in 1996. Tom has created in excess of $1.5B in shareholder value at companies which he founded.  Tom holds a B.S. in Industrial Engineering from Purdue University and an M.B.A. from Indiana University.  He is also active philanthropically with the Weldon School of Biomedical Engineering at Purdue University. 2009 Speakers List

 
Ralph Weinberger
Ralph Weinberger
Partner, Technology Industry Group
PricewaterhouseCoopers LLP
With over 24 years of service to life sciences and technology companies in the Twin Cities and Greater Minnesota, Ralph has worked with clients ranging in size from large global companies to high-growth small and mid-cap companies focused on developing into a global force.  In addition to coordinating delivery of high quality accounting and auditing services to his clients, Ralph has worked alongside his clients in addressing their needs for international expansion, mergers and acquisitions and accessing the public and private debt and equity markets.  Ralph is also the Treasurer of the Minnesota High Tech Association. List of Speakers

 
Fiona Wilmot, MD MPH
Fiona Wilmot, MD MPH
Glas Group Consulting
Fiona Wilmot runs Glas Group, a consulting business which advises in matters of health coverage, reimbursement and marketing strategy for medical devices and pharmaceuticals.  Prior to Glas Group Dr Wilmot served as the Medical Director of Policy, Pharmacy and Therapeutics for Blue Shield of California.  In this position she was responsible for developing medical policies related to new technologies and therapeutics, as well as serving as the Chair of the Pharmacy and Therapeutics Committee for 2.7 million covered lives.  Additionally she managed the Transplant Center of Excellence Program, spearheaded the External Review Program through the Department of Managed Care, and lead the Voluntary Review Program.
 
Dr. Wilmot has additional experience as a Regional Medical Director for Aetna US HealthCare’s ten state Western Region where she developed medical management strategies, was involved in new product development and sales support, and was tapped by leadership to lead key initiatives around best practices in national grievance and appeal processes.  Dr. Wilmot was the Associate Medical Director for a 5,000+ patient multi-specialty IPA in Northern California and was a member of member of one of the first hospitalist teams in Northern California.
 
Dr. Wilmot has a keen interest in public health and and so completed a Master’s in Public Health at the University of California Berkeley.  Her primary area of study was in Women's Health, Aging, and the Ethics of Resource Allocation.  Fiona has always sought roles that allow her to combine her full range of clinical training, focus on public health issues, and passion for delivering the best care for the patient at the right time in the right setting.
 
Dr. Wilmot graduated from Stanford University with distinction in English Literature and proceeded to earn her medical degree from the Boston University School of Medicine.  She also received a MPH from University of California, Berkeley.  She is board certified in Internal Medicine and is a member of the American College of Physician Executives. 2009 Speakers List

 

 
 
Internet marketing by AmazeMind.com